445 related articles for article (PubMed ID: 29458154)
21. Incidence of Esophageal Adenocarcinoma, Mortality, and Esophagectomy in Barrett's Esophagus Patients Undergoing Endoscopic Eradication Therapy.
Smith ZL; Thorgerson AM; Dawson AZ; Wani S
Dig Dis Sci; 2023 Dec; 68(12):4439-4448. PubMed ID: 37863992
[TBL] [Abstract][Full Text] [Related]
22. Advanced imaging in surveillance of Barrett's esophagus: Is the juice worth the squeeze?
Cerrone SA; Trindade AJ
World J Gastroenterol; 2019 Jul; 25(25):3108-3115. PubMed ID: 31333304
[TBL] [Abstract][Full Text] [Related]
23. Incidence of esophageal adenocarcinoma in Barrett's esophagus with low-grade dysplasia: a systematic review and meta-analysis.
Singh S; Manickam P; Amin AV; Samala N; Schouten LJ; Iyer PG; Desai TK
Gastrointest Endosc; 2014 Jun; 79(6):897-909.e4; quiz 983.e1, 983.e3. PubMed ID: 24556051
[TBL] [Abstract][Full Text] [Related]
24. Dedicated Barrett's surveillance sessions managed by trained endoscopists improve dysplasia detection rate.
Ooi J; Wilson P; Walker G; Blaker P; DeMartino S; O'Donohue J; Reffitt D; Lanaspre E; Chang F; Meenan J; Dunn JM
Endoscopy; 2017 Jun; 49(6):524-528. PubMed ID: 28399610
[No Abstract] [Full Text] [Related]
25. Risk of neoplastic progression in Barrett's esophagus diagnosed as indefinite for dysplasia: a nationwide cohort study.
Kestens C; Leenders M; Offerhaus GJ; van Baal JW; Siersema PD
Endoscopy; 2015 May; 47(5):409-14. PubMed ID: 25521571
[TBL] [Abstract][Full Text] [Related]
26. Lower Annual Rate of Progression of Short-Segment vs Long-Segment Barrett's Esophagus to Esophageal Adenocarcinoma.
Hamade N; Vennelaganti S; Parasa S; Vennalaganti P; Gaddam S; Spaander MCW; van Olphen SH; Thota PN; Kennedy KF; Bruno MJ; Vargo JJ; Mathur S; Cash BD; Sampliner R; Gupta N; Falk GW; Bansal A; Young PE; Lieberman DA; Sharma P
Clin Gastroenterol Hepatol; 2019 Apr; 17(5):864-868. PubMed ID: 30012433
[TBL] [Abstract][Full Text] [Related]
27. [Impact of endoscopic surveillance of Barrett's esophagus on survival of patients with esophageal adenocarcinoma].
Incarbone R; Bonavina L; Bassi F; Peracchia A
Chir Ital; 2002; 54(5):591-6. PubMed ID: 12469454
[TBL] [Abstract][Full Text] [Related]
28. Low Risk of High-Grade Dysplasia or Esophageal Adenocarcinoma Among Patients With Barrett's Esophagus Less Than 1 cm (Irregular Z Line) Within 5 Years of Index Endoscopy.
Thota PN; Vennalaganti P; Vennelaganti S; Young P; Gaddam S; Gupta N; Lieberman D; Sampliner R; Falk GW; Mathur S; Kennedy K; Cash BD; Moawad F; Bansal A; Spaander MC; Bruno MJ; Vargo J; Sharma P
Gastroenterology; 2017 Apr; 152(5):987-992. PubMed ID: 27988383
[TBL] [Abstract][Full Text] [Related]
29. Esophageal Adenocarcinoma: Screening, Surveillance, and Management.
Mansour NM; Groth SS; Anandasabapathy S
Annu Rev Med; 2017 Jan; 68():213-227. PubMed ID: 27618753
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
Wani S; Rubenstein JH; Vieth M; Bergman J
Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
[TBL] [Abstract][Full Text] [Related]
31. Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma.
Wani S; Falk G; Hall M; Gaddam S; Wang A; Gupta N; Singh M; Singh V; Chuang KY; Boolchand V; Gavini H; Kuczynski J; Sud P; Reddymasu S; Bansal A; Rastogi A; Mathur SC; Young P; Cash B; Lieberman DA; Sampliner RE; Sharma P
Clin Gastroenterol Hepatol; 2011 Mar; 9(3):220-7; quiz e26. PubMed ID: 21115133
[TBL] [Abstract][Full Text] [Related]
32. Endoscopic follow-up of Barrett's esophagus: protocol and implications.
De Looze D
Acta Gastroenterol Belg; 2000; 63(1):29-35. PubMed ID: 10907316
[TBL] [Abstract][Full Text] [Related]
33. Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with Barrett's oesophagus.
El-Serag HB; Naik AD; Duan Z; Shakhatreh M; Helm A; Pathak A; Hinojosa-Lindsey M; Hou J; Nguyen T; Chen J; Kramer JR
Gut; 2016 Aug; 65(8):1252-60. PubMed ID: 26311716
[TBL] [Abstract][Full Text] [Related]
34. Utility of confocal laser endomicroscopy in identifying high-grade dysplasia and adenocarcinoma in Barrett's esophagus: a systematic review and meta-analysis.
Gupta A; Attar BM; Koduru P; Murali AR; Go BT; Agarwal R
Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):369-77. PubMed ID: 24535597
[TBL] [Abstract][Full Text] [Related]
35. Barrett's oesophagus: Current controversies.
Amadi C; Gatenby P
World J Gastroenterol; 2017 Jul; 23(28):5051-5067. PubMed ID: 28811703
[TBL] [Abstract][Full Text] [Related]
36. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
[TBL] [Abstract][Full Text] [Related]
37. Early esophageal cancer in Europe: endoscopic treatment by endoscopic submucosal dissection.
Probst A; Aust D; Märkl B; Anthuber M; Messmann H
Endoscopy; 2015 Feb; 47(2):113-21. PubMed ID: 25479563
[TBL] [Abstract][Full Text] [Related]
38. Detection of lesions in dysplastic Barrett's esophagus by community and expert endoscopists.
Schölvinck DW; van der Meulen K; Bergman JJGHM; Weusten BLAM
Endoscopy; 2017 Feb; 49(2):113-120. PubMed ID: 27855466
[No Abstract] [Full Text] [Related]
39. Yield of Repeat Endoscopy in Barrett's Esophagus with No Dysplasia and Low-Grade Dysplasia: A Population-Based Study.
Visrodia K; Iyer PG; Schleck CD; Zinsmeister AR; Katzka DA
Dig Dis Sci; 2016 Jan; 61(1):158-67. PubMed ID: 25956705
[TBL] [Abstract][Full Text] [Related]
40. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
